WallStreetZenWallStreetZen

NASDAQ: CELZ
Creative Medical Technology Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CELZ stock forecasts and price targets.

Forecast return on equity

Is CELZ forecast to generate an efficient return?

Company
352.9%
Industry
91.96%
Market
170.37%
CELZ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CELZ forecast to generate an efficient return on assets?

Company
336.05%
Industry
27.83%
CELZ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CELZ earnings per share forecast

What is CELZ's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.60
Avg 2 year Forecast
-$1.54
Avg 3 year Forecast
$3.64

CELZ revenue forecast

What is CELZ's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$61.3M+2,042,633.33%
CELZ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CELZ revenue growth forecast

How is CELZ forecast to perform vs Biotechnology companies and vs the US market?

Company
2,472.43%
Industry
35.56%
Market
13.83%
CELZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CELZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CELZ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELZ$2.12N/AN/A
ASBP$6.05N/AN/A
XBIO$3.43N/AN/A
PMCB$0.73N/AN/A
ADXN$6.70N/AN/A
View Top Biotech Stocks

Creative Medical Technology Holdings Stock Forecast FAQ

What is CELZ's earnings growth forecast for 2026-2028?

(NASDAQ: CELZ) Creative Medical Technology Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.48%.

Creative Medical Technology Holdings's earnings in 2026 is -$5,761,988.On average, 3 Wall Street analysts forecast CELZ's earnings for 2026 to be -$5,919,844, with the lowest CELZ earnings forecast at -$5,687,693, and the highest CELZ earnings forecast at -$6,093,957. On average, 3 Wall Street analysts forecast CELZ's earnings for 2027 to be -$5,693,608, with the lowest CELZ earnings forecast at -$5,470,329, and the highest CELZ earnings forecast at -$5,861,067.

In 2028, CELZ is forecast to generate $13,461,047 in earnings, with the lowest earnings forecast at $12,933,163 and the highest earnings forecast at $13,856,960.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.

What is CELZ's revenue growth forecast for 2026-2028?

(NASDAQ: CELZ) Creative Medical Technology Holdings's forecast annual revenue growth rate of 2,472.43% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.83%.

Creative Medical Technology Holdings's revenue in 2026 is $3,000.On average, 3 Wall Street analysts forecast CELZ's revenue for 2026 to be $0, with the lowest CELZ revenue forecast at $0, and the highest CELZ revenue forecast at $0. On average, 3 Wall Street analysts forecast CELZ's revenue for 2027 to be $0, with the lowest CELZ revenue forecast at $0, and the highest CELZ revenue forecast at $0.

In 2028, CELZ is forecast to generate $226,539,208 in revenue, with the lowest revenue forecast at $217,652,419 and the highest revenue forecast at $233,200,604.

What is CELZ's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CELZ) forecast ROA is 336.05%, which is higher than the forecast US Biotechnology industry average of 27.83%.

What is CELZ's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CELZ) Creative Medical Technology Holdings's current Earnings Per Share (EPS) is -$2.14. On average, analysts forecast that CELZ's EPS will be -$1.60 for 2026, with the lowest EPS forecast at -$1.54, and the highest EPS forecast at -$1.65. On average, analysts forecast that CELZ's EPS will be -$1.54 for 2027, with the lowest EPS forecast at -$1.48, and the highest EPS forecast at -$1.59. In 2028, CELZ's EPS is forecast to hit $3.64 (min: $3.50, max: $3.75).

What is CELZ's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CELZ) forecast ROE is 352.9%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.